市場調查報告書
商品編碼
1396554
生物資訊服務市場 - 類型(定序服務、數據分析)、應用(基因組學、蛋白質組學、藥物基因組學)、最終用途(學術機構和研究中心、醫院和診所)、全球預測,2023 - 2032 年Bioinformatics Services Market - Type (Sequencing Services, Data Analysis), Application (Genomics, Proteomics, Pharmacogenomics), End-use, (Academic Institutes & Research Centers, Hospitals & Clinics), Global Forecast, 2023 - 2032 |
由於擴大採用生物資訊學工具來分析生物資料,預計從 2023 年到 2032 年,生物資訊服務市場的複合CAGR將達到 15.9%。隨著對精準醫療和個人化治療策略的需求不斷增加,製藥和生物技術公司越來越依賴生物資訊服務來解釋複雜的基因組和蛋白質組資料。
2023 年 12 月,領先的胃腸道健康公司 Cyted 獲得了 Innovate UK 的 100 萬英鎊資助,用於牽頭開展嗜酸性粒細胞性食道炎 (EoE) 診斷和治療反應預測的精準醫療計畫。
此外,生命科學領域研發活動的增加,加上政府推動基因組學研究的舉措,正在促進市場成長。
生物資訊服務市場根據類型、應用、最終用途和區域進行分類。
資料分析領域預計將在 2023 年至 2032 年期間創下強勁的CAGR,因為它涵蓋了廣泛的計算技術,可以從生物資料中提取有意義的見解。這正在影響重大創新,人工智慧和機器學習演算法的整合提高了資料解釋的效率和準確性。對於旨在從大規模生物資料集中獲得可行見解的研究人員和臨床醫生來說,這種演變至關重要。
到 2032 年,蛋白質組學應用將為市場帶來巨額收入,因為生物資訊服務有助於揭示蛋白質結構和功能的複雜性。用於蛋白質鑑定、表徵和定量的各種解決方案的可用性使研究人員能夠更深入地了解疾病機制、藥物標靶和生物標記發現。由於蛋白質體學領域在推進藥物發現和開發過程中發揮關鍵作用,預計將出現強勁成長。
在該地區強大的生命科學研發基礎設施的推動下,歐洲生物資訊學服務產業預計到 2032 年將顯著成長。領先的生物技術和製藥公司的存在,加上支持性的政府政策和資助計劃,使歐洲成為生物資訊服務提供者的中心。該地區學術機構、研究組織和產業參與者之間的合作激增,促進了生物資訊學應用的創新,從而塑造了產業前景。
Bioinformatics services market is predicted to observe 15.9% CAGR from 2023 to 2032 due to the growing adoption of bioinformatics tools for the analysis of biological data. With the escalating need for precision medicine and personalized treatment strategies, pharmaceutical and biotechnology companies are increasingly relying on bioinformatics services to interpret complex genomic and proteomic data.
In December 2023, Cyted, a leading gastrointestinal health firm, obtained a £1 million grant from Innovate UK to spearhead a precision medicine project for Eosinophilic Esophagitis (EoE) diagnosis and treatment response prediction.
Moreover, the rise in R&D activities in the life sciences sector, coupled with government initiatives promoting genomics research, is fostering market growth.
The bioinformatics services market is classified based on type, application, end-use, and region.
The data analysis segment is expected to record strong CAGR from 2023 to 2032 as it encompasses a wide array of computational techniques to extract meaningful insights from biological data. This is influencing significant innovation, with the integration of artificial intelligence and machine learning algorithms enhancing the efficiency & accuracy of data interpretation. This evolution is pivotal for researchers and clinicians aiming to derive actionable insights from large-scale biological datasets.
The proteomics application will generate massive revenues for the market by 2032 as bioinformatics services help in unraveling the complexities of protein structures and functions. The availability of various solutions for protein identification, characterization, and quantification, is enabling researchers to gain deeper insights into disease mechanisms, drug targets, and biomarker discovery. The proteomics segment is anticipated to witness robust growth owing to its pivotal role in advancing drug discovery and development processes.
Europe bioinformatics services industry is anticipated to grow significantly through 2032 driven by the region's robust infrastructure for life sciences R&D. The presence of leading biotechnology and pharmaceutical companies, coupled with supportive government policies and funding initiatives, positions Europe as a hub for bioinformatics service providers. The region is witnessing a surge in collaborations between academic institutions, research organizations, and industry players, fostering innovation in bioinformatics applications, thereby shaping the industry outlook.